Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000914190-09-000669
Filing Date
2009-09-28
Accepted
2009-09-28 21:02:00
Documents
1
Period of Report
2009-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6145
  Complete submission text file 0000914190-09-000669.txt   8031
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONOR MEDSYSTEMS, INC. 1003 HAMILTON COURT MENLO PARK CA 94025
Business Address
Litvack Frank (Reporting) CIK: 0001310715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 091091256